HCPCS Level II
J0573
Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- NDC crosswalk
- None in the loaded CMS ASP file
Codes near J0573
These sit next to J0573 in the CMS Level II file. All J codes
- J0565Injection, bezlotoxumab, 10 mg
- J0567Injection, cerliponase alfa, 1 mg
- J0570Buprenorphine implant, 74.2 mg
- J0571Buprenorphine, oral, 1 mg
- J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
- J0576Injection, buprenorphine extended-release (brixadi), 1 mg
- J0577Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- J0578Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy